Paper39349727
Developing a Coccidioides posadasii and SARS-CoV-2 Co-infection Model in the K18-hACE2 Transgenic Mouse.
Kollath DR and 14 others. Commun Med (Lond), 2024. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Developing a Coccidioides posadasii and SARS-CoV-2 Co-infection Model in the K18-hACE2 Transgenic Mouse. Papers, record 39349727. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39349727
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Developing a Coccidioides posadasii and SARS-CoV-2 Co-infection Model in the K18-hACE2 Transgenic Mouse.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U19 AI166058 | NIAID NIH HHS | United States | U19AI166058 | PubMed and NIH | NIH RePORTER |
| 5U19AI166058 | Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) | U19AI166058 | PubMed and NIH | NIH RePORTER | |
| Translational Research Initiative Fund Regent's award | Arizona Board of Regents (ABOR) | PubMed | PubMed |
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32,296,430 | Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development. | Front Immunol | 2020 | https://conductscience.org/library/papers/32296430 | PubMed |
| 2 | 36,930,672 | COVID-19 infection, reinfection, and the transition to endemicity. | Lancet | 2023 | https://conductscience.org/library/papers/36930672 | PubMed |
| 3 | 30,881,357 | Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells. | Front Immunol | 2019 | https://conductscience.org/library/papers/30881357 | PubMed |
| 4 | 34,788,127 | Pathogenesis of Respiratory Viral and Fungal Coinfections. | Clin Microbiol Rev | 2022 | https://conductscience.org/library/papers/34788127 | PubMed |
| 5 | 32,761,626 | What came first, the virus or the egg: Innate immunity during viral coinfections. | Immunol Rev | 2020 | https://conductscience.org/library/papers/32761626 | PubMed |
| 6 | 32,360,420 | Cytokine storm intervention in the early stages of COVID-19 pneumonia. | Cytokine Growth Factor Rev | 2020 | https://conductscience.org/library/papers/32360420 | PubMed |
| 7 | 34,367,879 | Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development. | Curr Trop Med Rep | 2019 | https://conductscience.org/library/papers/34367879 | PubMed |
| 8 | 33,824,495 | Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. | Nat Rev Microbiol | 2021 | https://conductscience.org/library/papers/33824495 | PubMed |
| 9 | 34,227,076 | Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology. | Eur Rev Med Pharmacol Sci | 2021 | https://conductscience.org/library/papers/34227076 | PubMed |
| 10 | 32,599,813 | COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. | J Fungi (Basel) | 2020 | https://conductscience.org/library/papers/32599813 | PubMed |
| 11 | 32,658,292 | A Chronic Murine Disease Model of Coccidioidomycosis Using Coccidioides posadasii, Strain 1038. | J Infect Dis | 2021 | https://conductscience.org/library/papers/32658292 | PubMed |
| 12 | 34,578,306 | Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons. | Viruses | 2021 | https://conductscience.org/library/papers/34578306 | PubMed |
| 13 | 33,167,717 | An Acute Pulmonary Coccidioidomycosis Coinfection in a Patient Presenting With Multifocal Pneumonia With COVID-19. | J Investig Med High Impact Case Rep | 2020 | https://conductscience.org/library/papers/33167717 | PubMed |
| 14 | 16,304,610 | Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. | PLoS Pathog | 2005 | https://conductscience.org/library/papers/16304610 | PubMed |
| 15 | 35,271,561 | Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. | MMWR Morb Mortal Wkly Rep | 2022 | https://conductscience.org/library/papers/35271561 | PubMed |
| 16 | 28,143,979 | Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic Pathogen. | mBio | 2017 | https://conductscience.org/library/papers/28143979 | PubMed |
| 17 | 36,441,757 | Drivers of respiratory syncytial virus seasonal epidemics in children under 5 years in Kilifi, coastal Kenya. | PLoS One | 2022 | https://conductscience.org/library/papers/36441757 | PubMed |
| 18 | 8,698,522 | Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. | Infect Immun | 1996 | https://conductscience.org/library/papers/8698522 | PubMed |
| 19 | 34,610,919 | Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada. | CMAJ | 2021 | https://conductscience.org/library/papers/34610919 | PubMed |
| 20 | 28,986,419 | Type III interferon is a critical regulator of innate antifungal immunity. | Sci Immunol | 2017 | https://conductscience.org/library/papers/28986419 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39349727
GET https://conductscience.org/api/papers/v1/39349727/references?page=2